Jens-Jorgen Larsen

Title: Jens-Jorgen Larsen: Innovator in Pharmaceutical Chemistry

Introduction

Jens-Jorgen Larsen is a notable inventor based in Hillerod, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical treatment. His work focuses on addressing disorders related to the acetylcholine or muscarinic system.

Latest Patents

Larsen holds a patent for "Tetrahydroisoxazolo[4,5-c]pyridine derivatives useful in the treatment." This invention relates to novel compounds that can be utilized in pharmaceutical compositions. The compounds are designed to treat disorders caused by the malfunction of the acetylcholine system. The patent details various individual isomers and pharmaceutically acceptable acid addition salts, highlighting the versatility of the compounds.

Career Highlights

Jens-Jorgen Larsen is associated with H. Lundbeck A/S, a prominent company in the pharmaceutical industry. His work at Lundbeck has allowed him to focus on innovative solutions for complex medical issues. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.

Collaborations

Larsen has collaborated with esteemed colleagues such as Erik Falch and Povl Krogsgaard-Larsen. These partnerships have contributed to the advancement of research and development in pharmaceutical applications.

Conclusion

Jens-Jorgen Larsen's contributions to pharmaceutical chemistry exemplify the impact of innovation in medical treatment. His patented work continues to influence the development of effective therapies for disorders related to the acetylcholine system.